Mindstate Design Labs
YC S21San Francisco, US · Founded 2021 · 7 employees · 1 known investors
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthMachine LearningMental Health TechTherapeuticsAIin /mindstate-design-labs@MindstateDesign
Founders & leadership· Y Combinator alumni (S21)
Investors · 1
In the news
- Psychedelics Without the Trip? Heavyweights Like Neuralink, Coinbase, Twitch Back AI Startup Developing 'Least Psychedelic Psychedelic' Drugfinance.yahoo.com · 2025
- A Startup Used AI to Make a Psychedelic Without the Trip | WIREDwired.com · 2025
- Mindstate Design Labs Secures $11.5 Million in Seed Funding for Innovative Psychedelic Therapeutics | Signalbasetrysignalbase.com · 2024
- FDA gives an early nod to psychedelic research - The Washington Postwashingtonpost.com · 2024
- Mindstate heads to the clinic with first AI-derived psychedelicfiercebiotech.com · 2024
- Transforming Psychedelics into Approved Medicinesgenengnews.com · 2022
- Are Hallucinogen Look-Alikes Illegal? DEA Delay Creates Limbobloomberg.com · 2022
- Psychedelics Provide New Frontier For Venture Funding, But Nuances Prevailnews.crunchbase.com · 2022